Table 1.
Baseline characteristic | Responders | Non-responders |
---|---|---|
(n = 66) | (n = 22) | |
Female gender, n (%) | 48 (73) | 18 (82) |
Age at onset of JIA in years, median (IQR) | 10.0 (4.2–12.3) | 9.4 (3.5–13.7) |
Disease duration in years, median (IQR) | 2.4 (1.1–4.9) | 2.3 (0.8–7.7) |
JADAS-10, median (IQR) | 20 (14–21) | 17 (11–22) |
CHAQ score, median (IQR) | 1.5 (0.7–2.2) | 1.3 (0.6-2.0) |
Number of active joints, median (IQR) | 11 (5–18) | 8 (2–16) |
ESR in mm/h, median (IQR) | 16 (9–28) | 12 (7–18) |
Number of previously used DMARDs, median (IQR) | 1 (1–2) | 1 (1–2) |
JIA juvenile idiopathic arthritis, JADAS juvenile arthritis disease activity score, IQR interquartile range, ESR erythrocyte sedimentation rate, CHAQ child health assessment questionnaire, DMARDs disease modifying anti-rheumatic drugs